Samuel G. Levy
Director/Board Member chez THERACLION
Profil
Samuel G.
Levy is the founder of Allurion Technologies, Inc. (Old) founded in 2009, and Lauxera Capital Partners SAS founded in 2020 where he holds the title of Founding Partner.
Currently, he holds director positions at Théraclion SA since 2016, Reapplix A, Vensica Medical Ltd., Veranex, Inc. since 2022, and iXLife Capital SAS since 2014.
He previously worked as a Consultant at McKinsey & Co., Inc. Dr. Levy received his undergraduate degree from Yale University and his doctorate from Harvard Medical School in 2012.
Postes actifs de Samuel G. Levy
| Sociétés | Poste | Début |
|---|---|---|
| THERACLION | Director/Board Member | 12/05/2016 |
Vensica Medical Ltd.
 Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | Director/Board Member | - |
iXLife Capital SAS
 iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Private Equity Investor | 01/12/2014 |
Lauxera Capital Partners SAS
 Lauxera Capital Partners SAS Investment ManagersFinance Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris. | Founder | 01/01/2020 |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Director/Board Member | - |
Veranex, Inc.
 Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | Director/Board Member | 19/05/2022 |
Anciens postes connus de Samuel G. Levy
| Sociétés | Poste | Fin |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Allurion Technologies, Inc. (Old)
 Allurion Technologies, Inc. (Old) Internet Software/ServicesTechnology Services Allurion Technologies, Inc. develops a treatment for obesity. The firm offers a medical device for obesity that can be delivered and removed without surgery or endoscopy. The company was founded by Shantanu k. Gaur and Samuel G. Levy in 2009 and is headquartered in Natick, MA. | Founder | - |
Formation de Samuel G. Levy
| Yale University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THERACLION | Health Technology |
| Entreprise privées | 7 |
|---|---|
Allurion Technologies, Inc. (Old)
Allurion Technologies, Inc. (Old) Internet Software/ServicesTechnology Services Allurion Technologies, Inc. develops a treatment for obesity. The firm offers a medical device for obesity that can be delivered and removed without surgery or endoscopy. The company was founded by Shantanu k. Gaur and Samuel G. Levy in 2009 and is headquartered in Natick, MA. | Technology Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Finance |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
Vensica Medical Ltd.
Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | Health Technology |
Lauxera Capital Partners SAS
Lauxera Capital Partners SAS Investment ManagersFinance Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris. | Finance |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | Technology Services |
